110 related articles for article (PubMed ID: 1743557)
1. Prognostic value of flow cytophotometric DNA content analysis in single treatment stage IB-IIA squamous cell carcinoma of the cervix.
Naus GJ; Zimmerman RL
Gynecol Oncol; 1991 Nov; 43(2):149-53. PubMed ID: 1743557
[TBL] [Abstract][Full Text] [Related]
2. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
3. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
[TBL] [Abstract][Full Text] [Related]
4. Polyclonal cervical tumors detected by flow cytometry.
Strang P; Stendahl U; Sorbe B
Anticancer Res; 1986; 6(2):171-5. PubMed ID: 3707052
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer.
Wimberger P; Hillemanns P; Kapsner T; Hepp H; Kimmig R
Anal Cell Pathol; 2002; 24(4-5):147-58. PubMed ID: 12590151
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
7. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
Lutgens LC; Schutte B; de Jong JM; Thunnissen FB
Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of preoperative DNA flow cytometry in surgically-treated cervical cancer.
Reich O; Pürstner P; Klaritsch P; Haas J; Lahousen M; Tamussino K; Winter R
Eur J Gynaecol Oncol; 2003; 24(1):13-7. PubMed ID: 12691309
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA content analysis of paraffin-embedded tissue derived from cervical carcinoma.
Konski A; Domenico D; Irving D; Tyrkus M; Neisler J; Phibbs G; Bishop K; Mah J; Eggleston W
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):839-43. PubMed ID: 7960985
[TBL] [Abstract][Full Text] [Related]
12. The uses and limitations of DNA flow cytometry in stage IB or II cervical carcinoma.
Lai CH; Hsueh S; Huang MY; Chang MF; Soong YK
Cancer; 1993 Dec; 72(12):3655-62. PubMed ID: 8252482
[TBL] [Abstract][Full Text] [Related]
13. S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix.
Strang P; Eklund G; Stendahl U; Frankendal B
Anticancer Res; 1987; 7(4B):807-10. PubMed ID: 3674766
[TBL] [Abstract][Full Text] [Related]
14. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
[TBL] [Abstract][Full Text] [Related]
16. The role of radical surgery followed by adjuvant therapy for high-risk early-stage cervical carcinoma patients with pelvic lymph node metastasis.
Lin H; ChangChien CC; Huang EY; Eng HL; Huang CC
Eur J Obstet Gynecol Reprod Biol; 2000 Nov; 93(1):85-90. PubMed ID: 11000510
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric DNA patterns in cervical carcinoma.
Strang P; Stendahl U; Frankendal B; Lindgren A
Acta Radiol Oncol; 1986; 25(4-6):249-54. PubMed ID: 3030052
[TBL] [Abstract][Full Text] [Related]
18. DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b.
Horn LC; Raptis G; Nenning H
Anal Quant Cytol Histol; 2002 Feb; 24(1):23-9. PubMed ID: 11865946
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
20. Flow cytometric and Ki-67 immunohistochemical analysis of cell cycle distribution of cervical cancer during radiation therapy.
Higuchi KH; Nakano T; Tsuboi A; Suzuki Y; Ohno T; Oka K
Anticancer Res; 2001; 21(4A):2511-8. PubMed ID: 11724315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
